Organon (OGN) Return on Invested Capital (2020 - 2026)
Organon (OGN) recorded quarterly Return on Invested Capital of 0.0% in Q1 2026, up 5.19% quarter-over-quarter from 0.0% in Q4 2025, and little changed on a YoY basis from 0.0% in Q1 2025.
Organon (OGN) Return on Invested Capital (2020 - 2026) Analysis & Trends
Organon's Return on Invested Capital history runs 7 years deep, the most recent figure standing at 0.0% for Q1 2026.
- In Q1 2026, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
- Return on Invested Capital was 0.0% for Q1 2026 at Organon, up from 0.0% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q1 2025 to a low of 0.0% in Q1 2024.
- Historically, Return on Invested Capital has averaged 0.0% across 5 years, with a median of 0.0% in 2022.
- Biggest YoY gain for Return on Invested Capital was 0 bps in 2022; the steepest drop was 0 bps in 2022.
- A 5-year view of Return on Invested Capital shows it stood at 0.0% in 2022, then sank by 160 bps to 0.0% in 2023, then surged by 123 bps to 0.0% in 2024, then plunged by 31 bps to 0.0% in 2025, then advanced by 5 bps to 0.0% in 2026.
- The last three Return on Invested Capital figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,026,132.38 Bn | 93,026,127.42 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 1,022.62 Bn | 1,017.34 Bn | 16.22 Bn | 0.00% |
| 3 | Johnson & Johnson | 570.65 Bn | 548.59 Bn | 15.96 Bn | 0.00% |
| 4 | AbbVie | 398.73 Bn | 389.38 Bn | 10.78 Bn | 0.00% |
| 5 | Merck | 295.53 Bn | 289.88 Bn | 12.09 Bn | 0.00% |
| 6 | Amgen | 186.30 Bn | 174.26 Bn | 5.87 Bn | 0.00% |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn | 0.00% |
| 8 | Pfizer | 146.09 Bn | 133.32 Bn | -1.21 Bn | 0.00% |
| 9 | Bristol Myers Squibb | 114.98 Bn | 104.53 Bn | 8.07 Bn | 0.00% |
| 10 | Organon | 3.49 Bn | 2.37 Bn | 783.00 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |